Creatine supplementation prevents statin-induced muscle toxicity

Annals of Internal Medicine

Volumn 153, Issue 10, 2010, Pages 690-692

  Shewmon, David A ^a   Craig, John M ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CREATINE KINASE; CREATININE; STATIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; DISEASE SEVERITY; DRUG WITHDRAWAL; HEART RATE; HUMAN; LABORATORY TEST; MAINTENANCE THERAPY; MUSCLE CRAMP; MUSCLE WEAKNESS; MYOPATHY; PRIORITY JOURNAL; SUPPLEMENTATION; UREA NITROGEN BLOOD LEVEL; VISUAL ANALOG SCALE;

EID: 78751695812     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-10-201011160-00024     Document Type: Article

References (5)

1. Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al; Scripps Mercy Clinical Research Center. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137:581-5. [PMID: 12353945]
2. Askari A, Vignos PJ Jr, Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med. 1976;61:485-92. [PMID: 973643]
3. Meyer RA. A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol. 1988;254:C548-53. [PMID: 3354652]
4. De Pinieux G, Chariot P, Ammi-Saïd M, Louarn F, Lejonc JL, Astier A, et al. Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol. 1996;42:333-7. [PMID: 8877024] (Pubitemid 26284422)
5. Tran TT, Dai W, Sarkar HK. Cyclosporin A inhibits creatine uptake by altering surface expression of the creatine transporter. J Biol Chem. 2000;275:35708-14. [PMID: 10964923]